共 62 条
- [1] CHEN J, SARMA B, EVANS J M B, Et al., Pharmaceutical crystallization, Crystal Growth & Design, 11, 4, pp. 887-895, (2011)
- [2] BROG J P, CHANEZ C L, CROCHET A, Et al., Polymorphism, what it is and how to identify it: a systematic review, RSC Advances, 3, 38, pp. 16905-16931, (2013)
- [3] CHEN Guiliang, LI Junchan, PENG Xingsheng, Et al., Drug polymorphism and related quality control, Chinese Journal of Pharmaceutical Analysis, 32, 8, pp. 1503-1508, (2012)
- [4] YANG Shiying, ZHOU Jian, ZHANG Li, Et al., Present situation and progress of the research for polymorphic chemical drugs in China, Herald of Medicine, 38, 2, pp. 177-182, (2019)
- [5] WENG J Y, HUANG Y P, HAO D L, Et al., Recent advances of pharmaceutical crystallization theories, Chinese Journal of Chemical Engineering, 28, 4, pp. 935-948, (2020)
- [6] HATAKKA H, ALATALO H, LOUHI-KULTANEN M, Et al., Closed-loop control of reactive crystallization part II: polymorphism control of L-glutamic acid by sonocrystallization and seeding, Chemical Engineering & Technology, 33, 5, pp. 751-756, (2010)
- [7] WU C S, HSIEH P Y, YUYAMA K I, Et al., Pseudopolymorph control of L-phenylalanine achieved by laser trapping, Crystal Growth & Design, 18, 9, pp. 5417-5425, (2018)
- [8] WEISSBUCH I, TORBEEV V Y, LEISEROWITZ L, Et al., Solvent effect on crystal polymorphism: why addition of methanol or ethanol to aqueous solutions induces the precipitation of the least stable β form of glycine, Angewandte Chemie International Edition, 44, 21, pp. 3226-3229, (2005)
- [9] DING L, ZONG S H, DANG L P, Et al., Effects of inorganic additives on polymorphs of glycine in microdroplets, CrystEngComm, 20, 2, pp. 164-172, (2018)
- [10] SONG R Q, COLFEN H., Additive controlled crystallization, CrystEngComm, 13, 5, pp. 1249-1276, (2011)